Portland, OR -- (ReleaseWire) -- 07/03/2014 --Neuroprotective products are used in protecting the brain neurons from injury or degeneration. They are extremely helpful in treatment of several CNS disorders such as Alzheimer's disease, traumatic brain injuries and Parkinson's disease. Since the risk of Neurodegenerative diseases increases with age, Neurodegenerative diseases are common among the aged population. Further, with a rise in the life span of the population, there is greater scope for the Neuroprotective products market. Increasing incidences of brain injuries due to road accidents are also driving the market growth. However, strict government regulations, high rate of failure of the drugs in the clinical trials and requirement of high investment would impede the market growth.
In terms of drugs, the market is segmented into Cholinesterase Inhibitors, Ion Channel Modulators, Anti-Inflammatory and Anti-Apoptotic Agents, NMDA Receptor Antagonists, Mitochondrial Dysfunction Regulators, Neurotropic Factors, Ion Channel Modulators, Anti Excitotoxic Agents , Metal Ion Chelators Free Radical Trappers, and others.
To Browse complete report visit: http://www.alliedmarketresearch.com/neuroprotective-products-market
NMDA receptor antagonists and Cholinesterase inhibitors are used in the treatment of Alzheimers. Since Alzheimers occurs at a high rate, the above two drugs are expected to lead the market.
The Neuroprotective products are used in the treatment of Alzheimer's disease, Parkinson's disease, Brain injury, Multiple Sclerosis, Retinal disorders, Huntington's disease, Neuropathies, Amyotrophic Lateral Sclerosis (ALS), and other disorders affecting the nervous system.
Around 60,000 cases of Parkinson’s disease are diagnosed in North America every year. Hence, North America dominates the market for Neuroprotective products. Europe and Asia-Pacific are expected to witness growth in the Neuroprotective products market due to rising number of cases of neurodegenerative diseases.
Similar Market Studies by Allied Market Research:
Global Anti-Counterfeit Packaging Market: http://www.alliedmarketresearch.com/anti-counterfeit-market
Global Weight Loss and Obesity Market: http://www.alliedmarketresearch.com/weight-loss-obesity-market
The report provides detailed information regarding strategies employed by the key market players . Key firms include:-
Genervon Biopharmaceuticals
NeuroVive Pharmaceutical,Ceregene
BHRPharma LLC
Neuren Pharmaceuticals
Allon therapeutics, Inc.
Bionure Inc
About Us:
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in capturing most accurate market data and confirms utmost accuracy of our market forecasts. Each and every data presented in the reports published by us is also extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
Sona Padman
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
United States
Direct: +1(617)674-4143
Toll Free: +1(855)711-1555 (U.S. & Canada)
Fax: +1(855)550-5975
E-mail: sales@alliedmarketresearch.com
Web: http://www.alliedmarketresearch.com/
Neuroprotective Products Market Analyzed by Allied Market Research
Since the risk of Neurodegenerative diseases increases with age, Neurodegenerative diseases are common among the aged population. Further, with a rise in the life span of the population, there is greater scope for the Neuroprotective products market.